Form D · Other Health Care
Women's & Children's Health Technology EU Fund SCSp
Luxembourg, N4 · CIK 0001907736
Offering snapshot reported Feb 14, 2022 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $142K Reported outside-investor minimum
- First sale
- Dec 13, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2022 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-433461
Limited Partnership Interests
Source: Form D, filed Feb 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
WOMEN'S AND CHILDREN'S HEALTH TECHNOLOGY EU FUND SCSP
Investment adviser: CROSS-BORDER IMPACT VENTURES LTD.
- Gross asset value
- $67.4M
- Beneficial owners
- 30
- ADV minimum commitment
- $250K
Reported in Form ADV on Apr 1, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- Yes
- External marketing
- Yes
ERNST AND YOUNG LLP
PCAOB 1263
Filing source
Form ADV 2089043 · Apr 1, 2026 · Schedule D 7.B.(1), fund 805-8548483991
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Annie Theriault | Executive |
| Sigridur Torfadottir | Executive |
| Hugo Vautier | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:Luxembourg, N4, 2557